Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)

Inclusion Criteria: * Behçet's disease diagnosis fulfilling the International Study Group Classification Criteria. * History of Behçet's disease uveitis with ocular involvement of the posterior segment. * Patients with a stable background treatment of oral corticosteroid and at least one immunosuppressive drug. * Male or female, age ≥18 (or legal age of majority in the country) at selection * For subjects with reproductive potential, a willingness to use highly effective contraceptive measures Exclusion Criteria: * Infectious uveitis, uveitis due to causes other than Behçet's disease. * Monocular vision * Presence of severe cataract or severe posterior capsular opacification. * Contraindication to mydriasis or presence of posterior synechiae. * Active TB disease. * History of severe allergic or anaphylactic reactions to monoclonal antibodies * History of malignancy within 5 years prior to Selection. Other protocol-defined inclusion/exclusion criteria may apply